10.25402/EPI.21285438.V1
Yan Hou
Yan
Hou
Kang Li
Kang
Li
Liuying Wang
Liuying
Wang
Shuang Li
Shuang
Li
Min Zhang,
Min
Zhang,
Yue Huang
Yue
Huang
Meng Wang
Meng
Wang
Liuchao Zhang
Liuchao
Zhang
Zhenyi Xu
Zhenyi
Xu
A novel subtype to predict prognosis and treatment response with DNA driver methylation–transcription in ovarian cancer.
<p> </p>
<p>TableS1. Clinical data of ovarian cancer patients from TCGA and ICGC.</p>
<p><br></p>
<p> </p>
<p>TableS2.Identified DNA driver methylation (DNAme) in TCGA, ICGC and GSE146556.</p>
<p><br></p>
<p> </p>
<p>TableS3. The correlation between DNAme and corresponding mRNA expression in TCGA, ICGC and GSE146556.</p>
<p> </p>
<p>TableS4.Analysis of pathway enrichment (KEGG) and Gene Ontology (GO) of DNAme-associated mRNA in TCGA.</p>
<p><br></p>
<p> </p>
<p>TableS5. Univariate Cox regression analysis of DNAme-associated mRNA. (<em>P</em> < 0.05)</p>
<p><br></p>
<pre><code>TableS6. Analysis of pathway enrichment (KEGG) and Gene Ontology (GO) of prognostic significance DNAme-associated mRNA in TCGA.</code></pre>
<p> </p>
<p>TableS7.Clinicopathological information of DNAme-associated subtypes in TCGA</p>
<p> </p>
<p>TableS8.Gene set enrichment analysis (GSEA) of three subtypes in TCGA</p>
<p> </p>
<p><strong>Table S9.</strong> Abbreviations list</p>
Epigenetics (incl. genome methylation and epigenomics)
Future Science Group
2022
2022-10-06
2024-02-16
Figure
7481897 Bytes
10.25402/EPI.21285438
10.2217/epi-2022-0206
CC BY-NC-ND 4.0